TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    After Reaching Another 52-Week High, Valeant Pharmaceuticals Intl Inc. Should Still Be Avoided at All Costs!

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) should still be avoided at all costs.

    Read more »

    Investing

    2 Fallen Stars That Will Fly High Again

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two businesses that have reinvented themselves. Here's why you should…

    Read more »

    Investing

    4 Non-Cannabis Stocks That Have Grown 25% in the Past 3 Months

    Bombardier, Inc. (TSX:BBD.B) and these three other stocks could provide investors with excellent growth opportunities.

    Read more »

    The Motley Fool
    Investing

    Queue the 2018 Rebound for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be slated to enjoy a huge 2018. Here's why investors may want to back…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals International Inc. Is Trading at 52-Week Highs: Should You Buy or Sell?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is still in early stages of a comeback, with many hurdles to overcome.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Recent Debt Offering a Genius Move

    By refinancing $1.5 billion of debt due in 2020, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) CEO Joe Papa has continued to impress…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Surges ~12% in a Day: Why the Stock Could Easily Double in 2018

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) surged along with the biotech and pharma industry. Here's why investors should expect more big…

    Read more »

    Dividend Stocks

    New to Investing? Avoid These 5 “Rookie” Mistakes

    Follow these five tips that will help you avoid common pitfalls of investing in stocks such as Valeant Pharmaceuticals Intl…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Best Long-Term Rebound Play on the TSX?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) looks like it's on the road to a rebound. Here's why investors may want to…

    Read more »

    Investing

    Aurora Cannabis Inc. Surges ~153% in a Month: Can it Catch Up to Canopy Growth Corp.?

    Are Aurora Cannabis Inc. (TSX:ACB) shares too hot to handle at current levels? Or is the company going after Canopy…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: If You’d Bought the Dip, You’re up

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has had a great month, and it could continue to ride that wave.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Opportunity or Value Trap?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has shown signs of improvement under Joseph Papa. Should investors take a risk on the…

    Read more »